MA24239A1 - Melange comprenant de la virginiamycine, procede pour sa preparation et traitement de denrees avec ce melange - Google Patents

Melange comprenant de la virginiamycine, procede pour sa preparation et traitement de denrees avec ce melange

Info

Publication number
MA24239A1
MA24239A1 MA24696A MA24696A MA24239A1 MA 24239 A1 MA24239 A1 MA 24239A1 MA 24696 A MA24696 A MA 24696A MA 24696 A MA24696 A MA 24696A MA 24239 A1 MA24239 A1 MA 24239A1
Authority
MA
Morocco
Prior art keywords
virginiamycin
foodstuffs
mixture
preparation
treatment
Prior art date
Application number
MA24696A
Other languages
English (en)
Inventor
William Carson James
Hollett Fahrenholz Charles
William Chapin Frederic
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA24239A1 publication Critical patent/MA24239A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
MA24696A 1996-07-01 1997-06-30 Melange comprenant de la virginiamycine, procede pour sa preparation et traitement de denrees avec ce melange MA24239A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2051296P 1996-07-01 1996-07-01

Publications (1)

Publication Number Publication Date
MA24239A1 true MA24239A1 (fr) 1997-12-31

Family

ID=21799022

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24696A MA24239A1 (fr) 1996-07-01 1997-06-30 Melange comprenant de la virginiamycine, procede pour sa preparation et traitement de denrees avec ce melange

Country Status (15)

Country Link
EP (2) EP0906098A1 (fr)
JP (2) JPH11514001A (fr)
KR (1) KR100395607B1 (fr)
AP (1) AP9701038A0 (fr)
AU (1) AU2786297A (fr)
BR (1) BR9710019A (fr)
CA (1) CA2259298A1 (fr)
DZ (1) DZ2256A1 (fr)
IL (1) IL127565A0 (fr)
MA (1) MA24239A1 (fr)
NZ (1) NZ333301A (fr)
PL (1) PL330961A1 (fr)
TR (1) TR199802741T2 (fr)
WO (1) WO1998000136A1 (fr)
ZA (1) ZA975805B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2408796C (fr) * 2000-05-24 2009-12-15 Otsuka Pharmaceutical Co., Ltd. Procede servant a stabiliser une preparation
WO2005013964A1 (fr) 2003-08-08 2005-02-17 Ajinomoto Co., Inc. Preparation pharmaceutique contenant du nateglinide
WO2005053727A2 (fr) * 2003-11-29 2005-06-16 Sangstat Medical Corporation Compositions pharmaceutiques pour agents peptidiques bioactifs
WO2013052956A2 (fr) 2011-10-07 2013-04-11 E. I. Du Pont De Nemours And Company Compositions liquides utilisées comme moyens isolant et de transfert de chaleur, dispositifs électriques contenant lesdites compositions et procédés de préparation de telles compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE819863A (fr) * 1974-09-13 1975-03-13 Compositions d'antibiotiques du type virginiamycine pour administration orale.
US5266347A (en) * 1992-01-28 1993-11-30 Ducoa L.P. Antibiotic biomass animal feed compositions
ES2124794T3 (es) * 1992-10-09 1999-02-16 Kanegafuchi Chemical Ind Procedimiento para producir granulados finos.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
WO1995011598A1 (fr) * 1993-10-26 1995-05-04 Lachlan Macsmith Aliment en boulettes a haute valeur nutritive pour ruminants
KR100819863B1 (ko) * 2001-09-03 2008-04-07 엘지.필립스 엘시디 주식회사 유량측정장치

Also Published As

Publication number Publication date
JPH11514001A (ja) 1999-11-30
DZ2256A1 (fr) 2002-12-18
BR9710019A (pt) 1999-08-10
EP1147770A1 (fr) 2001-10-24
IL127565A0 (en) 1999-10-28
JP2002316931A (ja) 2002-10-31
NZ333301A (en) 1999-09-29
ZA975805B (en) 1998-12-30
TR199802741T2 (xx) 1999-03-22
KR20000022446A (ko) 2000-04-25
KR100395607B1 (ko) 2004-01-31
WO1998000136A1 (fr) 1998-01-08
AU2786297A (en) 1998-01-21
CA2259298A1 (fr) 1998-01-08
EP0906098A1 (fr) 1999-04-07
PL330961A1 (en) 1999-06-21
AP9701038A0 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
MA26431A1 (fr) Procede pour la preparation des arylpyrimidines, leur utilisation pour preparer des medicaments et pour traiter un mamifere dont l'etat pathologique peut etre attenue par traitement avec antagoniste du 5ht2b
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
FR2764887B1 (fr) Melange de diphenylamines nonylees, procede pour le preparer et composition le contenant
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
EP0690023A3 (fr) Xérogels, leur procédé de préparation et leur utilisation
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
GR3036279T3 (en) Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation.
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
FI971268A7 (fi) Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
FR2722210B1 (fr) Nouvelles streptogramines et procede de preparation de streptogramines par mutasynthese
EE9900162A (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
FR2680506B1 (fr) Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
GR80698B (en) N-cyclized benzenesulfonamides, process for the preparation thereof and their use as active substances in pharmaceutical compositons
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
FR2690152B1 (fr) Procede de preparation et de traitement de propulseurs.
MA20154A1 (fr) Derives de 3-phenyl-4 cyanopyrole,procede pour leur preparation et elur application comme microbicides
FR2666334B1 (fr) Procede continu de preparation d'acrylamides et de methacrylamides n-substitues.
MA24239A1 (fr) Melange comprenant de la virginiamycine, procede pour sa preparation et traitement de denrees avec ce melange
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
FI971081L (fi) Triatsolopyridatsiinit, menetelmä ja välituotteet niiden valmistamiseksi sekä niiden käyttö lääkeaineina
FI971267A7 (fi) Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
IL117078A (en) Substituted benzenesulfonylureas and-thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them